Solving Unique Challenges in Oncology Trials Using Advanced IRT Functionality

How Celgene used Suvoda's flexible and configurable IRT system to help simplify complexities and find solutions to common obstacles in oncology trials

How Celgene Used IRT to Find Solutions to Common Obstacles in Oncology Trials
An advanced IRT system that has the flexibility to handle unique aspects of oncology studies can simplify the complexity of managing such studies and dramatically reduce the burden on the sponsor. To implement a flexible IRT system successfully, it’s important to look at new ways to approach system functionality that can account for the “known” unknowns that make oncology trials especially difficult to design and maintain.

What You Will Learn

Watch this webinar to learn how Suvoda helped Celgene design a system that is flexible enough to handle:

  • Subject-specific dynamic visit schedules to manage an unknown number of repeating cycles
  • Unknown cohorts and cohort doses
  • Unknown number of unscheduled, dose titrating visits
  • Multiple phase management with different disease/tumor type management per phase

Published May 2018